Validity Of Patient-Reported Outcomes From Columbus, A Randomized Open Label Phase Iii Clinical Trial Of Encorafenib Plus Binimetinib VS Vemurafenib In Advanced Braf-Mutant Melanoma
Abstract
Authors
N Rahhali Y Chalem J Niemira CW van Gils C Blome L Gerlier